Optimi Health Corp. (CSE:OPTI)
6.80
-0.10 (-1.45%)
Aug 10, 2026, 3:59 PM EST
Optimi Health Revenue
Optimi Health had revenue of 99.50K CAD in the quarter ending March 31, 2026, with 62.47% growth. This brings the company's revenue in the last twelve months to 231.86K, down -53.24% year-over-year. In the fiscal year ending September 30, 2025, Optimi Health had annual revenue of 426.30K with 9.35% growth.
Revenue (ttm)
231.86K
Revenue Growth
-53.24%
P/S Ratio
170.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
39.51M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 426.30K | 36.45K | 9.35% |
| Sep 30, 2024 | 389.85K | 208.76K | 115.28% |
| Sep 30, 2023 | 181.09K | 100.37K | 124.35% |
| Sep 30, 2022 | 80.72K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Planet 13 Holdings | 134.62M |
| Decibel Cannabis Company | 121.32M |
| Vext Science | 72.54M |
| Rubicon Organics | 60.76M |
| C21 Investments | 45.53M |
| MediPharm Labs | 43.28M |
| LSL Pharma Group | 28.74M |
| ZYUS Life Sciences | 413.00K |
Optimi Health News
- 6 weeks ago - Optimi Health completes psilocybin export to Australia - TheFly
- 6 weeks ago - Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - GlobeNewsWire
- 7 weeks ago - Optimi launches standardized microdose psilocybin products for clinical research - TheFly
- 7 weeks ago - Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research - GlobeNewsWire
- 2 months ago - Psychedelic: Optimi Health completes psilocybin export to the UK - TheFly
- 2 months ago - Optimi Health completes first export of naturally derived psilocybin to the UK - TheFly
- 2 months ago - Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial - GlobeNewsWire
- 2 months ago - Optimi Health commences finished ibogaine drug product development - TheFly